Impaired or dysregulated PP2A methylation is believed to increase the risk of Alzheimer’s disease via hyperhomocysteinemia, an abnormally high level of serum homocysteine [76]. This evidence concerns the gene PTPA and early-onset autosomal dominant Alzheimer disease.